๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma

โœ Scribed by Toni K. Choueiri; Zita Dubauskas Lim; Michelle S. Hirsch; Pheroze Tamboli; Eric Jonasch; David F. McDermott; Paola Dal Cin; Paul Corn; Ulka Vaishampayan; Daniel Y.C. Heng; Nizar M. Tannir


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
315 KB
Volume
116
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Clinical factors associated with outcome
โœ Toni K. Choueiri; Jorge A. Garcia; Paul Elson; Mohamad Khasawneh; Saif Usman; Al ๐Ÿ“‚ Article ๐Ÿ“… 2007 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 124 KB ๐Ÿ‘ 2 views

## Abstract ## BACKGROUND. Therapy targeted against the vascular endothelial growth factor (VEGF) pathway is a standard of care for patients with metastatic renal cell carcinoma (RCC). The identification of patients who are more likely to benefit from these agents is warranted. ## METHODS. In to